Prevalence of metabolic syndrome in obese women with polycystic ovary syndrome

2014 ◽  
Author(s):  
Ivana Bozic Antic ◽  
Djuro Macut ◽  
Jelica Bjekic-Macut ◽  
Danijela Vojnovic Milutinovic ◽  
Milan Petakov ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Obese Women ◽  
Ovary Syndrome

scholarly journals Evaluation of DNA damage profile in obese women and its association to risk of metabolic syndrome, polycystic ovary syndrome and recurrent preeclampsia

2018 ◽  
Vol 5 (4) ◽  
pp. 367-373 ◽  
Author(s):  
Moushira Zaki ◽  
Walaa Basha ◽  
Hala T. El-Bassyouni ◽  
Safinaz El-Toukhy ◽  
Tamer Hussein
Keyword(s):  
Metabolic Syndrome ◽  
Dna Damage ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Obese Women ◽  
Ovary Syndrome

scholarly journals Metabolic syndrome in women with polycystic ovary syndrome: prevalence, characteristics and predictors

2007 ◽  
Vol 51 (6) ◽  
pp. 972-979 ◽  
Author(s):  
José Antonio M. Marcondes ◽  
Sylvia A.Y. Hayashida ◽  
Cristiano R.G. Barcellos ◽  
Michelle P. Rocha ◽  
Gustavo A.R. Maciel ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Body Mass Index ◽  
Polycystic Ovary Syndrome ◽  
Body Mass ◽  
Polycystic Ovary ◽  
Hdl Cholesterol ◽  
Morbidly Obese ◽  
Age Difference ◽  
Obese Women ◽  
Ovary Syndrome

The aim of this study was to determine the prevalence of metabolic syndrome in women with polycystic ovary syndrome, as well as its characteristics and predictors. Seventh-three women, with body mass index of 30.4 ± 7.8 kg/m² and 25.0 ± 6.0 years old, subdivided according to body mass index, were studied retrospectively. There was no significant mean age difference among body mass index groups (p = 0.228). Prevalence of metabolic syndrome was 38.4%, with a null prevalence for normal (n = 18), 23.8% for overweight (n = 17), 62.9% for obese (n = 28), and 85.5% for morbidly obese women (n = 7). Women with metabolic syndrome were older than women without metabolic syndrome (27.3 ± 5.3 vs. 24.2 ± 4.6 vs. years old; p = 0.031) and presented a higher body mass index (36.3 ± 7.7 vs. 26.9 ± 5.4; p < 0.001). There was no difference for degree of hirsutism and menstrual patterns between women with and without metabolic syndrome (p = 0.593 and p = 0.119, respectively). Regarding laboratory parameters, DHEAS was lower (1,646 ± 1,007 vs. 2,594 ± 1,563; p = 0.007) and HOMA-IR were higher (9.9 ± 9.7 vs. 4.6 ± 4.7; p = 0.004) in women with metabolic syndrome (p = 0.031 and p < 0.001, respectively). The best predictors of metabolic syndrome were waist circumference > 88 cm, HDL-cholesterol < 50 mg/dL and triglycerides > 150 mg/dL.

scholarly journals Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome

2017 ◽  
Vol 107 (4) ◽  
pp. 1048-1054 ◽  
Author(s):  
Peiwen Liang ◽  
Liuqing Xi ◽  
Juan Shi ◽  
Wanyu Li ◽  
Shaoqian Zhao ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Reproductive Age ◽  
Obese Women ◽  
Women Of Reproductive Age ◽  
Ovary Syndrome

scholarly journals Pre-pregnancy preparation in women with polycystic ovary syndrome and obesity: state-of-the-art

2021 ◽  
Vol 4 (2) ◽  
pp. 137-143
Author(s):  
I.A. Lapina ◽  
◽  
T.G. Chirvon ◽  
Yu.E. Dobrokhotova ◽  
V.V. Taranov ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Polycystic Ovary Syndrome ◽  
State Of The Art ◽  
Polycystic Ovary ◽  
Reproductive Function ◽  
Lifestyle Changes ◽  
Medical Community ◽  
Obese Women ◽  
Ovary Syndrome ◽  
Lipid Metabolism Disorders

In recent decades, extensive growth in the number of overweight or obese individuals is reported thus making this issue important for the medical community. According to some authors, 8% of overweight women and 18% of obese women have troubles with realizing reproductive function. Glucose and lipid metabolism disorders and hypertension that are common in women with polycystic ovary syndrome (PCOS) allow for referring this condition to metabolic diseases. Metabolic syndrome is an umbrella term for a set of metabolic abnormalities arising from insulin resistance and hyperinsulinemia. PCOS may also be considered as one of its manifestations being regarded as the most common cause of infertility in overweight and obese women. The treatment should be complex to recover reproductive function and to address metabolic disorders. Adherence to lifestyle changes, diet, and regular physical activity is still poor. Therefore, the use and assessment of the efficacy of pharmaceuticals for pre-pregnancy preparation to lose weight and to improve reproductive outcomes in PCOS. KEYWORDS: polycystic ovary syndrome, PCOS, obesity, metabolic syndrome, infertility, pre-pregnancy preparation, treatment, prevention, ovulation. FOR CITATION: Lapina I.A., Chirvon T.G., Dobrokhotova Yu.E., Taranov V.V. Pre-pregnancy preparation in women with polycystic ovary syndrome and obesity: state-of-the-art. Russian Journal of Woman and Child Health. 2021;4(2):137–143. DOI: 10.32364/2618-8430- 2021-4-2-137-143.

Value of lipid accumulation product for the assessment of metabolic syndrome in women with polycystic ovary syndrome

2013 ◽  
Author(s):  
Antic Ivana Bozic ◽  
Jelica Bjekic-Macut ◽  
Dimitrios Panidis ◽  
Danijela Vojnovic Milutinovic ◽  
Biljana Kastratovic ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Polycystic Ovary Syndrome ◽  
Lipid Accumulation ◽  
Polycystic Ovary ◽  
Lipid Accumulation Product ◽  
Ovary Syndrome

High prevalence of multimorbidity in overweight and obese women with Polycystic Ovary Syndrome (PCOS)

2017 ◽  
Author(s):  
Hamidreza Mani ◽  
Yogini Chudasama ◽  
Danielle Bodicoat ◽  
Miles Levy ◽  
Laura Gray ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Obese Women ◽  
Ovary Syndrome ◽  
High Prevalence
Sign in / Sign up

Export Citation Format

Share Document